NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

This grant program has established specific submission guidelines, including a singular Letter of Intent (LOI) deadline for all applications, which is due on July 24, 2023. Following the LOI, there are set deadlines for the submission of full proposals, which must be adhered to strictly. These deadlines are at 5:00 pm local time of the applicant organization on the following dates: August 24, 2023; February 16, 2024; and February 16, 2025. The details provided focus on the administrative and procedural aspects of the grant application process rather than the specific causes or sectors the grant aims to support.

Eligibility

Organization's Location
USA, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, British Virgin Islands
Program Location
USA, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands
Organization Type
up to 5M

Submission

Visit Apply for more information.

Similar grants